Respiratory tract

Respiratory Combo Antigen Rapid TestD(COVID-19/Flu A&Flu B/RSV/ADV)(Nasal)

The COVID-19/RSV/ADV/FLU A&B Antigen Rapid Test is a lateral flow immunoassay intended for the in vitro rapid, simultaneous qualitative  detection and differentiation of nucleocapsid antigen from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), Influenza type A  virus, Influenza type B virus, Respiratory Syncytial Virus (RSV), and Adenovirus (ADV) directly from anterior nasal swab specimens obtained  from individuals, who are suspected of respiratory viral infection consistent with COVID-19 by their healthcare providers, within the first seven days of symptoms onset.